Tuesday, December 6, 2022
wellness India Expo
Home Tags Biopharma

Tag: biopharma

Merck to acquire Imago BioSciences for US$1.35 billion

Imago is a clinical stage biopharmaceutical company developing new medicines for the treatment of myeloproliferative neoplasms (MPNs) and other bone marrow diseases

BioVoice eMagazine November 2022 Issue 2 Volume 3

Click to Read: BioVoice News November 2022 Issue 2 Volume 3 The Cover Story in the current edition turns its spotlight on the genetically modified mustard. Its recent...

Biocon ranks No. 8 in ‘Global Top Employers’ by Science magazine

The company has been ranked 8th on the list this year for three key attributes: ‘innovative leader in the industry’, ‘is socially responsible’ and ‘has loyal employees’

C-CAMP signs agreement with Agilent to boost scientific advancements in biopharma

Through this partnership, both organizations will leverage each other’s capabilities to hold joint training sessions and seminars for researchers across biopharma

Exclusive: Antibody against multiple emerging SARS-CoV-2 variants

A broadly neutralizing highly potent human monoclonal antibody developed in India against multiple emerging SARS-CoV-2 variants

7th advanced GMP workshop by IPA to strengthen manufacturing practices &...

The workshops help improve the understanding on core issues such as quality management, global best practices, and new technologies in manufacturing

Cryogenic freezing has become a critical process step in advanced therapeutics

Michael Wieland, Senior Director and Head of Global Applications Services at Single Use Support shares his views on the multiple challenges that can occur in the field of cryopreservation

Kiran Mazumdar Shaw honored with H.K. Firodia Lifetime Achievement Award 2022

The selection committee unanimously decided to confer the award on the Biocon chief for her monumental contributions as a global leader in biotechnology innovation and entrepreneurship

Emerging technologies ushering life sciences industry into metaverse, says Accenture Report

91% of medical technology and 85% of biopharma executives expect new technologies to have a positive impact on the industry

Daiichi Sankyo initiates phase 3 trial of mRNA based covid vaccine

The trial is an active-controlled, trial to investigate the non-inferiority of DS-5670 to an already-approved mRNA vaccine